Last reviewed · How we verify

Lidocaine %2 ampoule

Kaohsiung Medical University Chung-Ho Memorial Hospital · FDA-approved active Small molecule

Lidocaine %2 ampoule is a Local anesthetic Small molecule drug developed by Kaohsiung Medical University Chung-Ho Memorial Hospital. It is currently FDA-approved for Local anesthesia for infiltration, nerve blocks, and regional anesthesia, Topical anesthesia for minor surgical procedures. Also known as: jetmonal.

Lidocaine blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses to produce local anesthesia.

Lidocaine blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses to produce local anesthesia. Used for Local anesthesia for infiltration, nerve blocks, and regional anesthesia, Topical anesthesia for minor surgical procedures.

At a glance

Generic nameLidocaine %2 ampoule
Also known asjetmonal
SponsorKaohsiung Medical University Chung-Ho Memorial Hospital
Drug classLocal anesthetic
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesia
PhaseFDA-approved

Mechanism of action

Lidocaine is a local anesthetic that works by inhibiting sodium influx through voltage-gated sodium channels in the neuronal cell membrane. This prevents depolarization and the generation of action potentials, thereby blocking pain signal transmission in the injected area. It has a rapid onset and intermediate duration of action, making it suitable for infiltration anesthesia, nerve blocks, and topical applications.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Lidocaine %2 ampoule

What is Lidocaine %2 ampoule?

Lidocaine %2 ampoule is a Local anesthetic drug developed by Kaohsiung Medical University Chung-Ho Memorial Hospital, indicated for Local anesthesia for infiltration, nerve blocks, and regional anesthesia, Topical anesthesia for minor surgical procedures.

How does Lidocaine %2 ampoule work?

Lidocaine blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses to produce local anesthesia.

What is Lidocaine %2 ampoule used for?

Lidocaine %2 ampoule is indicated for Local anesthesia for infiltration, nerve blocks, and regional anesthesia, Topical anesthesia for minor surgical procedures.

Who makes Lidocaine %2 ampoule?

Lidocaine %2 ampoule is developed and marketed by Kaohsiung Medical University Chung-Ho Memorial Hospital (see full Kaohsiung Medical University Chung-Ho Memorial Hospital pipeline at /company/kaohsiung-medical-university-chung-ho-memorial-hospital).

Is Lidocaine %2 ampoule also known as anything else?

Lidocaine %2 ampoule is also known as jetmonal.

What drug class is Lidocaine %2 ampoule in?

Lidocaine %2 ampoule belongs to the Local anesthetic class. See all Local anesthetic drugs at /class/local-anesthetic.

What development phase is Lidocaine %2 ampoule in?

Lidocaine %2 ampoule is FDA-approved (marketed).

What are the side effects of Lidocaine %2 ampoule?

Common side effects of Lidocaine %2 ampoule include Lightheadedness or dizziness, Nervousness or anxiety, Tremor, Allergic reactions (rare), Methemoglobinemia (with excessive doses).

What does Lidocaine %2 ampoule target?

Lidocaine %2 ampoule targets Voltage-gated sodium channels and is a Local anesthetic.

Related